Kalfarentzos E, Chliaoutakis A, Ntagiantis G, Vardas E, Christopoulos P. Orthodontic treatment as triggering factor of medication related osteonecrosis of the Jaw in a breast cancer patient. Report of a rare case. J Clin Exp Dent. 2023;15(4):e351-6.

doi:10.4317/jced.60046

__________

References

1. Ruggiero SL, Dodson TB, Fantasia J, Goodday R, Aghaloo T, Mehrotra B, et al. American association of oral and maxillofacial surgeons position paper on medication-related osteonecrosis of the jaw - 2014 update. Journal of Oral and Maxillofacial Surgery. 2014;72:1938-56. https://doi.org/10.1016/j.joms.2014.04.031 PMid:25234529

2. Ghoneima AA, Allam ES, Zunt SL, Windsor LJ. Bisphosphonates treatment and orthodontic considerations. Orthodontics and Craniofacial Research. 2010;13:1-10. https://doi.org/10.1111/j.1601-6343.2009.01472.x PMid:20078789

3. Baron R, Ferrari S, Russell RGG. Denosumab and bisphosphonates: Different mechanisms of action and effects. Bone. 2011;48:677-92. https://doi.org/10.1016/j.bone.2010.11.020 PMid:21145999

4. Rinchuse DJ, Rinchuse DJ, Sosovicka MF, Robison JM, Pendleton R. Orthodontic treatment of patients using bisphosphonates: A report of 2 cases. Am J Orthod Dentofac Orthop. 2007;131:321-6. https://doi.org/10.1016/j.ajodo.2006.11.002 PMid:17346586

5. Bartzela T, Türp JC, Motschall E, Maltha JC. Medication effects on the rate of orthodontic tooth movement: A systematic literature review. American Journal of Orthodontics and Dentofacial Orthopedics. 2009;135:16-26. https://doi.org/10.1016/j.ajodo.2008.08.016 PMid:19121496

6. Zahrowski JJ. Optimizing orthodontic treatment in patients taking bisphosphonates for osteoporosis. Am J Orthod Dentofac Orthop. 2009;135:361-74. https://doi.org/10.1016/j.ajodo.2008.08.017 PMid:19268836

7. Iglesias-Linares A, Yáñez-Vico RM, Solano-Reina E, Torres-Lagares D, González Moles MÁ. Influence of bisphosphonates in orthodontic therapy: Systematic review. Journal of Dentistry. 2010;38:603-11. https://doi.org/10.1016/j.jdent.2010.05.012 PMid:20546824

8. Hellstein JW, Adler RA, Edwards B, Jacobsen PL, Kalmar JR, Koka S, et al. Managing the care of patients receiving antiresorptive therapy for prevention and treatment of osteoporosis. J Am Dent Assoc. 2011;142:1243-51. https://doi.org/10.14219/jada.archive.2011.0108 PMid:22041409

9. Abela S, Chotai M, Bister D. What you need to know about bisphosphonates: An overview and general recommendations for orthodontic treatment. J Orthod. 2012;39:186-92. https://doi.org/10.1179/1465312512Z.00000000022 PMid:22984103

10. Krieger E, Jacobs C, Walter C, Wehrbein H. Current state of orthodontic patients under Bisphosphonate therapy. Head Face Med. 2013;9:10. https://doi.org/10.1186/1746-160X-9-10 PMid:23556517 PMCid:PMC3637297

11. Zahrowski JJ. Bisphosphonate treatment: An orthodontic concern calling for a proactive approach. Am J Orthod Dentofac Orthop. 2007;131:311-20. https://doi.org/10.1016/j.ajodo.2006.09.035 PMid:17346585